FDA Accepts Resubmission for RP1 Oncolytic Immunotherapy Plus Nivolumab in PD-1–Refractory Melanoma

FDA Accepts Resubmission for RP1 Oncolytic Immunotherapy Plus Nivolumab in PD-1–Refractory Melanoma

OncoDaily Party Berlin 2025: A Night Where Oncology Met Energy

OncoDaily Party Berlin 2025 ESMO

100 Influential People in Oncology 2025 - Nominations are Open!

100 Influential People in Oncology 2025

International Cardio-Oncology Society Introduced the GCOS 2025 Social Media Ambassador Team

International Cardio-Oncology Society Introduced the GCOS 2025 Social Media Ambassador Team

Iza-bren (EGFR×HER3 bispecific ADC) 303 Study: Late-breaking ESMO presentation, The Lancet publication, and press-conference Q&A highlights

iza-bren egfrxher3 bispecific press release

Katy Rezvani: Comprehensive Overview of Engineered Natural Killer Cells for Cancer Therapy

Katy Rezvani

Zihai Li: First-In-Human Anti-GARP CAR-T Trial for Patients With Relapsed GBM

Zihai Li

Enrique Soto: New ASCO Global Guideline on Geriatric Assessment

Enrique Soto

OncoCalendar

Loading Events

« All Events

ESID-EHA-SIOPE Focused Symposium 2025

Nov 18 • 12:00 AM - Nov 20 • 12:00 AM
ESID-EHA-SIOPE Focused Symposium 2025

ESID-EHA-SIOPE Focused Symposium 2025 will take place in Vienna, 18-20 November 2025.

The ESID-EHA-SIOPE 2025 symposium will be a landmark event that brings together leading experts from the fields of immunology, haematology, and paediatric oncology to explore the critical intersections between these specialties. Titled “The Interplay of Immunology and Haematology” the symposium aims to foster collaboration and discussion on how advancements in each of these areas can improve the diagnosis, treatment, and management of patients with complex, multi-faceted conditions. The event promises an immersive experience where professionals will share their insights and innovative approaches in addressing the evolving challenges in patient care.

As patient cases become increasingly intricate, these specialties are more interconnected than ever before. The symposium will provide a unique platform to explore the complex relationships between immunodeficiencies, hematologic, and oncologic conditions, helping clinicians develop more comprehensive, multidisciplinary approaches. Participants will have the opportunity to examine pathophysiological links among these fields, discussing the latest best practices for screening, integrated treatment, and patient management. With a focus on driving better patient outcomes through collective expertise, the event will encourage deep discussions on how collaboration across these fields can enhance patient care and treatment efficacy.

The ESID-EHA-SIOPE 2025 symposium will also feature cutting-edge research, with an emphasis on scientific discovery and its application in clinical practice. Attendees can expect to learn about the latest breakthroughs in immunodeficiencies, haematology, and oncology, and contribute to the growing body of knowledge in these fields. The event is particularly encouraging for fellows, researchers, and junior faculty, offering a platform for them to present and discuss novel basic and clinical information. By uniting experts from three pivotal societies, this symposium marks a new era of collaboration, with the shared goal of improving patient outcomes through a multidisciplinary approach to complex health challenges.

For Registration, visit here.
For Abstract Submission, visit here.

Details

Start:
Nov 18 • 12:00 AM
End:
Nov 20 • 12:00 AM
Website:
https://esidmeeting.org/esid-eha-siope/

Venue

Vienna, Austria
Vienna, 1300 Austria + Google Map